LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

LLY

776.45

-2.39%↓

JNJ

152.33

+0.12%↑

ABBV

182.26

-2.5%↓

NVO

68.53

+1.17%↑

UNH

308.74

+2.11%↑

Search

STAAR Surgical Co

Затворен

СекторЗдравеопазване

16.92 0.59

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

16.45

Максимум

17.14

Ключови измерители

By Trading Economics

Приходи

-20M

-54M

Продажби

-6.4M

43M

P/E

Средно за сектора

55.443

50.291

EPS

-1.005

Марж на печалбата

-127.289

Служители

1,157

EBITDA

-43M

-71M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+14.47% upside

Дивиденти

By Dow Jones

Следващи печалби

6.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

33M

826M

Предишно отваряне

16.33

Предишно затваряне

16.92

Настроения в новините

By Acuity

50%

50%

154 / 380 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

STAAR Surgical Co Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

26.06.2025 г., 23:49 ч. UTC

Печалби

Nike Sees Sales Decline Decelerating in 1Q as Turnaround Strategy Plays Out -- 2nd Update

26.06.2025 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

FTC Clears Alimentation Couche-Tard's $1.57 Billion GetGo Acquisition

26.06.2025 г., 21:30 ч. UTC

Печалби

Nike 4Q Profit, Revenue Slides as Turnaround Strategy Plays Out -- Update

26.06.2025 г., 21:07 ч. UTC

Печалби

Nike 4Q Profit, Revenue Slide as Turnaround Strategy Plays Out

26.06.2025 г., 23:49 ч. UTC

Пазарно говорене

Nikkei May Rise as Fears About Middle East Conflict Ebb -- Market Talk

26.06.2025 г., 23:39 ч. UTC

Пазарно говорене

Gold Edges Lower, Weighed by Stronger-Than-Expected U.S. Data -- Market Talk

26.06.2025 г., 23:34 ч. UTC

Придобивния, сливания и поглъщания

Wesfarmers: Lease Reset Provides Opportunity for Upgrades, Extensions

26.06.2025 г., 23:33 ч. UTC

Придобивния, сливания и поглъщания

Wesfarmers: 62 BWP-Owned Bunnings Sites Get Significantly Longer Leases

26.06.2025 г., 23:32 ч. UTC

Придобивния, сливания и поглъщания

Wesfarmers Will No Longer Receive Earnings From BWP Management

26.06.2025 г., 23:32 ч. UTC

Придобивния, сливания и поглъщания

Wesfarmers to Increase BWP Holding to 23.5% From 22.3%

26.06.2025 г., 23:31 ч. UTC

Придобивния, сливания и поглъщания

Wesfarmers: New BWP Units Priced at 9.2% Premium to Last Close

26.06.2025 г., 23:31 ч. UTC

Придобивния, сливания и поглъщания

BWP to Pay A$100 Mln Cash, A$42.6 Mln in New Units

26.06.2025 г., 23:30 ч. UTC

Придобивния, сливания и поглъщания

Wesfarmers' Bunnings, BWP Trust to Extend and Vary Leases

26.06.2025 г., 23:29 ч. UTC

Придобивния, сливания и поглъщания

Wesfarmers to Sell BWP Management to BWP Trust for A$142.6M

26.06.2025 г., 23:19 ч. UTC

Придобивния, сливания и поглъщания

Andlauer Healthcare Group: Ontario Superior Court of Justice Issues Final Order Approving Sale to UPS

26.06.2025 г., 22:06 ч. UTC

Печалби

Nike's Earnings Were Ugly. But They're Better Than Feared. -- Barrons.com

26.06.2025 г., 21:15 ч. UTC

Печалби

Nike 4Q Profit, Rev Slides as Turnaround Strategy Plays Out -- Update

26.06.2025 г., 21:07 ч. UTC

Придобивния, сливания и поглъщания

Couche-Tard: 35 Stores to Be Divested in Accordance With Regulatory Requirements >ATD.T

26.06.2025 г., 21:07 ч. UTC

Придобивния, сливания и поглъщания

Couche-Tard: GetGo Will Operate as Separate, Stand-Alone Business Unit, Maintain myPerks Loyalty Program >ATD.T

26.06.2025 г., 21:07 ч. UTC

Придобивния, сливания и поглъщания

Couche-Tard: Buyer Will be Approved by the FTC >ATD.T

26.06.2025 г., 21:07 ч. UTC

Печалби

Nike's Earnings Were Ugly. But They're Better Than Feared. -- Barrons.com

26.06.2025 г., 21:06 ч. UTC

Придобивния, сливания и поглъщания

Couche-Tard Agreed to Sell 35 Sites, Including 34 Circle K Locations and One GetGo Property >ATD.T

26.06.2025 г., 21:06 ч. UTC

Придобивния, сливания и поглъщания

Couche-Tard: Transaction Is Expected to Close in the Coming Days >ATD.T

26.06.2025 г., 21:06 ч. UTC

Пазарно говорене

Bank of Mexico Seen Likely to Slow Pace of Rate Cuts -- Market Talk

26.06.2025 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

COUCHE-TARD RECEIVES FTC CLEARANCE TO COMPLETE ACQUISITION OF GETGO CAFÉ + MARKET >ATD.T

26.06.2025 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

COUCHE-TARD RECEIVES FTC CLEARANCE TO COMPLETE ACQUISITION OF GETGO CAFÉ + MARKET >ATD.T

26.06.2025 г., 20:52 ч. UTC

Печалби

Nike 4Q Profit, Rev Slide as Turnaround Strategy Plays Out

26.06.2025 г., 20:51 ч. UTC

Печалби

Correct: Nike 4Q Net $211M, Not $200M >NKE

26.06.2025 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

26.06.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

STAAR Surgical Co Прогноза

Ценова цел

By TipRanks

14.47% нагоре

12-месечна прогноза

Среден 19.14 USD  14.47%

Висок 27 USD

Нисък 13 USD

Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за STAAR Surgical Co през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

9 ratings

2

Купи

6

Задържане

1

Продай

Техническа оценка

By Trading Central

18.604 / 20.07Подкрепа & съпротива

Краткосрочен план

Strong Bullish Evidence

Средносрочен план

Very Strong Bullish Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

154 / 380 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.